Home The Word Brain My Amedeo FAQ Privacy About   


As of October 2023, Amedeo had
12,263 active subscribers


  Cervical Cancer, June 2023

Free Subscription


Abstracts

Retrieve all available abstracts of the following 277 articles:
HTML format


 

Single Articles

  1. HEALTHCARE ENGINEERING JO
    Retracted: Dose Prediction Models Based on Geometric and Plan Optimization Parameter for Adjuvant Radiotherapy Planning Design in Cervical Cancer Radiotherapy.
    J Healthc Eng. 2023;2023:9865373.
    PubMed    
    Abstract available

  2. ZHU X, Yao Q, Dai W, Ji L, et al
    Cervical cancer screening aided by artificial intelligence, China.
    Bull World Health Organ. 2023;101:381-390.
    PubMed    
    Abstract available

  3. PARNA K, Nygard M, Tisler A, Toompere K, et al
    Age-specific and genotype-specific carcinogenic human papillomavirus prevalence in a country with a high cervical cancer burden: results of a cross-sectional study in Estonia.
    BMJ Open. 2023;13:e069558.
    PubMed    
    Abstract available

  4. GOULENOK T, Mendes C, Dayan L, Ferre VM, et al
    Improving Human Papillomavirus-Related Cervical Cancer Screening in Patients With Systemic Lupus Erythematosus.
    J Rheumatol. 2023 Jun 1:jrheum.2022-1335. doi: 10.3899/jrheum.2022-1335.
    PubMed    
    Abstract available

  5. RONSINI C, Solazzo MC, Molitierno R, De Franciscis P, et al
    Fertility-Sparing Treatment for Early-Stage Cervical Cancer >/= 2 cm: Can One Still Effectively Become a Mother? A Systematic Review of Fertility Outcomes.
    Ann Surg Oncol. 2023 Jun 1. doi: 10.1245/s10434-023-13542.
    PubMed    
    Abstract available

  6. MORSE RM, Jurczuk M, Brown J, Jara LEC, et al
    "Day or night, no matter what, I will go": Women's perspectives on challenges with follow-up care after cervical cancer screening in Iquitos, Peru: a qualitative study.
    BMC Womens Health. 2023;23:293.
    PubMed    
    Abstract available

  7. GUO X, Dou Y, Liu S, Du Y, et al
    Elevated Expression of ADAM10 Induced by HPV E6 Influences the Prognosis of Cervical Cancer.
    Genet Test Mol Biomarkers. 2023;27:165-171.
    PubMed    
    Abstract available

  8. KIM YN, Lee K, Park E, Park J, et al
    Comprehensive genomic and immunohistochemical profiles and outcomes of immunotherapy in patients with recurrent or advanced cervical cancer.
    Front Oncol. 2023;13:1156973.
    PubMed    
    Abstract available

  9. FANTIN C, Freitas JB, Teles HFM, Oliveira BAS, et al
    High prevalence of HPV 18 and multiple infections with oncogenic HPV genotypes in women at risk of cervical cancer examined in Manaus, Brazil.
    Braz J Med Biol Res. 2023;56:e12720.
    PubMed    
    Abstract available

  10. LI B, Hua C, Tian P, Sha Y, et al
    25-hydroxycholesterol inhibits human papillomavirus infection in cervical epithelial cells by perturbing cytoskeletal remodeling.
    J Med Virol. 2023;95:e28834.
    PubMed    
    Abstract available

  11. MORI AT, Nyabakari CJ
    Cost of image-guided percutaneous nephrostomy among cervical cancer patients at Muhimbili National Hospital in Tanzania.
    Cost Eff Resour Alloc. 2023;21:33.
    PubMed    
    Abstract available

  12. KARAMAGI HC, Ben Charif A, Afriyie DO, Sy S, et al
    Mapping health service coverage inequalities in Africa: a scoping review protocol.
    BMJ Open. 2023;13:e068903.
    PubMed    
    Abstract available

  13. CHEN J, Han Y, Hu Y, Feng X, et al
    Neoadjuvant camrelizumab plus chemotherapy for locally advanced cervical cancer (NACI Study): a study protocol of a prospective, single-arm, phase II trial.
    BMJ Open. 2023;13:e067767.
    PubMed    
    Abstract available

  14. MOUKHLISSI M, Samba S, Najioui Y, Bennani A, et al
    [A rare case of botryoid sarcoma of the uterine cervix: case report].
    Pan Afr Med J. 2023;44:102.
    PubMed    
    Abstract available

  15. GUO Y, Jin G, Gao YY, Li K, et al
    Clinical study of interstitial brachytherapy for 72 cases of recurrent cervical cancer.
    Pak J Med Sci. 2023;39:863-869.
    PubMed    
    Abstract available

  16. JIANG S, Cui Z, Zheng J, Wu Q, et al
    Significance of Immunogenic Cell Death-Related Prognostic Gene Signature in Cervical Cancer Prognosis and Anti-Tumor Immunity.
    J Inflamm Res. 2023;16:2189-2207.
    PubMed    
    Abstract available

  17. FINK G, Abdulcadir J, Johnson-Agbakwu CE
    Rates of Cervical Cancer Screening and Dysplasia Among Refugees in a Health Care Safety Net System.
    J Immigr Minor Health. 2023 May 30. doi: 10.1007/s10903-023-01491.
    PubMed    
    Abstract available

  18. HUANG S, Mai X, Liu H, Sun W, et al
    Plan quality and treatment efficiency assurance of two VMAT optimization for cervical cancer radiotherapy.
    J Appl Clin Med Phys. 2023 May 29:e14050. doi: 10.1002/acm2.14050.
    PubMed    
    Abstract available

  19. RODRIGUEZ OUTEIRAL R, Gonzalez PJ, Schaake EE, van der Heide UA, et al
    Deep learning for segmentation of the cervical cancer gross tumor volume on magnetic resonance imaging for brachytherapy.
    Radiat Oncol. 2023;18:91.
    PubMed    
    Abstract available

  20. WANG W, Luo H, Chang J, Yang X, et al
    Circular RNA circ0001955 promotes cervical cancer tumorigenesis and metastasis via the miR-188-3p/NCAPG2 axis.
    J Transl Med. 2023;21:356.
    PubMed    
    Abstract available

  21. GAO X, Zhang W, Sun J, Adeloye D, et al
    Lifetime prevalence and adherence rate of cervical cancer screening among women living with HIV: a systematic review and meta-analysis.
    J Int AIDS Soc. 2023;26:e26090.
    PubMed    
    Abstract available

  22. DAVIES P, Aluloski I, Aluloski D, Brcanski J, et al
    HPV Vaccination and Cervical Cancer Screening Policies and Practices in 18 Countries, Territories and Entities across Eastern Europe and Central Asia.
    Asian Pac J Cancer Prev. 2023;24:1781-1788.
    PubMed    
    Abstract available

  23. WANNASIN R, Likitdee N, Kelly M, Thinkhamrop K, et al
    Survival after Diagnosis of Cervical Cancer Patients at a Tertiary Referral Hospital in Northeast Thailand.
    Asian Pac J Cancer Prev. 2023;24:1759-1767.
    PubMed    
    Abstract available

  24. MAPITIGAMA N, Moonesinghe LN, Punchihewa R, Perera C, et al
    A Descriptive Study of Different Methods of Cervical Cancer Screening among Ever-Married Women in 35-Year and 45-Year Cohorts in Kalutara District, Sri Lanka.
    Asian Pac J Cancer Prev. 2023;24:1487-1493.
    PubMed    
    Abstract available

  25. KEBAYOON A, Wiwanitkit V
    Comment on Self-Sampling Methodology Impression for Cervical Cancer Screening.
    Asian Pac J Cancer Prev. 2023;24:1449-1451.
    PubMed    


  26. TIAN M, Wang H, Liu X, Ye Y, et al
    Delineation of clinical target volume and organs at risk in cervical cancer radiotherapy by deep learning networks.
    Med Phys. 2023 May 29. doi: 10.1002/mp.16468.
    PubMed    
    Abstract available

  27. ABDUL-LATIF M, Tharmalingam H, Tsang Y, Hoskin PJ, et al
    Functional Magnetic Resonance Imaging in Cervical Cancer Diagnosis and Treatment.
    Clin Oncol (R Coll Radiol). 2023 May 18:S0936-6555(23)00184.
    PubMed    
    Abstract available

  28. RE GL, Cucinella G, Zaccaria G, Crapanzano A, et al
    Role of MRI in the Assessment of Cervical Cancer.
    Semin Ultrasound CT MR. 2023;44:228-237.
    PubMed    
    Abstract available

  29. ZHAO W, Liu YK, Li DJ, Zhao XW, et al
    The role of interferon-stimulated gene 15 in the occurence and progression of cervical squamous cell carcinoma.
    J Physiol Pharmacol. 2023;74.
    PubMed    
    Abstract available

  30. LIANG C, Jiang H, Sun L, Kang S, et al
    Which factors predict parametrial involvement in stage IB cervical cancer? A Chinese multicentre study.
    Eur J Surg Oncol. 2023 May 19:S0748-7983(23)00504.
    PubMed    
    Abstract available

  31. KOHLER RE, Hemler J, Wagner RB, Sullivan B, et al
    Confusion and anxiety in between abnormal cervical cancer screening results and colposcopy: "The land of the unknown".
    Patient Educ Couns. 2023;114:107810.
    PubMed    
    Abstract available

  32. DALIANIS T, von Buchwald C, Nasman A, Syrjanen S, et al
    Special Issue "HPV in the Head and Neck Region 2.0".
    Viruses. 2023;15:1119.
    PubMed    
    Abstract available

  33. PAYANO VJH, Lopes LVA, Peixoto LR, Silva KAD, et al
    Immunostaining of betaA-Activin and Follistatin Is Decreased in HPV(+) Cervical Pre-Neoplastic and Neoplastic Lesions.
    Viruses. 2023;15:1031.
    PubMed    
    Abstract available

  34. JAGARAN K, Singh M
    Copolymer-Green-Synthesized Copper Oxide Nanoparticles Enhance Folate-Targeting in Cervical Cancer Cells In Vitro.
    Polymers (Basel). 2023;15:2393.
    PubMed    
    Abstract available

  35. FU J, Lu L, Li M, Guo Y, et al
    A gamma-Glutamyl Transpeptidase (GGT)-Triggered Charge Reversal Drug-Delivery System for Cervical Cancer Treatment: In Vitro and In Vivo Investigation.
    Pharmaceutics. 2023;15:1335.
    PubMed    
    Abstract available

  36. ANDREIKA L, Vankeviciene K, Plioplyte M, Bitinaityte M, et al
    Multiple Rare Primary Malignancies: A Mixed Squamous Neuroendocrine Adenocarcinoma of the Cervix, Metastasized Carcinosarcoma and Extramammary Vulvar Paget's Disease Case Report.
    Medicina (Kaunas). 2023;59:995.
    PubMed    
    Abstract available

  37. SCHUBERT M, Bauerschlag DO, Muallem MZ, Maass N, et al
    Challenges in the Diagnosis and Individualized Treatment of Cervical Cancer.
    Medicina (Kaunas). 2023;59:925.
    PubMed    
    Abstract available

  38. SONG C, Jang TK, Kong S, Kang H, et al
    Robotic Single-Site Radical Hysterectomy for Early Cervical Cancer: A Single Center Experience of 5 Years.
    J Pers Med. 2023;13:733.
    PubMed    
    Abstract available

  39. PSILOPATIS I, Vrettou K, Giaginis C, Theocharis S, et al
    The Role of Bitter Melon in Breast and Gynecological Cancer Prevention and Therapy.
    Int J Mol Sci. 2023;24:8918.
    PubMed    
    Abstract available

  40. AVILA E, Noriega-Mejia BJ, Gonzalez-Macias J, Cortes-Hernandez U, et al
    The Preventive Role of the Vitamin D Endocrine System in Cervical Cancer.
    Int J Mol Sci. 2023;24:8665.
    PubMed    
    Abstract available

  41. ABDULLAH H, Ismail I, Suppian R, Zakaria NM, et al
    Natural Gallic Acid and Methyl Gallate Induces Apoptosis in Hela Cells through Regulation of Intrinsic and Extrinsic Protein Expression.
    Int J Mol Sci. 2023;24:8495.
    PubMed    
    Abstract available

  42. EVANDE R, Rana A, Biswas-Fiss EE, Biswas SB, et al
    Protein-DNA Interactions Regulate Human Papillomavirus DNA Replication, Transcription, and Oncogenesis.
    Int J Mol Sci. 2023;24:8493.
    PubMed    
    Abstract available

  43. AASBO G, Hansen BT, Waller J, Nygard M, et al
    Unpacking the Lay Epidemiology of Cervical Cancer: A Focus Group Study on the Perceptions of Cervical Cancer and Its Prevention among Women Late for Screening in Norway.
    Healthcare (Basel). 2023;11:1441.
    PubMed    
    Abstract available

  44. TOMIC SD, Coric A, Tomic S, Mujicic E, et al
    Cervical Cancer Prevention Knowledge (Cckp-64) among Female Students in Novi Sad, Serbia during COVID-19 Pandemic.
    Healthcare (Basel). 2023;11:1400.
    PubMed    
    Abstract available

  45. CHEN CY, Kung PT, Chiu LT, Tsai WC, et al
    Comparison of Cervical Cancer Screening Used between Individuals with Disabilities and Individuals without Disabilities.
    Healthcare (Basel). 2023;11:1363.
    PubMed    
    Abstract available

  46. MUSTAFA WA, Ismail S, Mokhtar FS, Alquran H, et al
    Cervical Cancer Detection Techniques: A Chronological Review.
    Diagnostics (Basel). 2023;13:1763.
    PubMed    
    Abstract available

  47. NASIOUDIS D, George EM, Tanyi JL
    Controversies in the Staging of Patients with Locally Advanced Cervical Cancer.
    Diagnostics (Basel). 2023;13:1747.
    PubMed    
    Abstract available

  48. KUTZ JM, Rausche P, Gheit T, Puradiredja DI, et al
    Barriers and facilitators of HPV vaccination in sub-saharan Africa: a systematic review.
    BMC Public Health. 2023;23:974.
    PubMed    
    Abstract available

  49. AKAKPO PK, Ken-Amoah S, Enyan NIE, Agyare E, et al
    High-risk human papillomavirus genotype distribution among women living with HIV; implication for cervical cancer prevention in a resource limited setting.
    Infect Agent Cancer. 2023;18:33.
    PubMed    
    Abstract available

  50. XIE S, Zhao J, Wang X, Hu Y, et al
    The distribution pattern of pelvic lymph nodal metastases in cervical cancer.
    J Cancer Res Clin Oncol. 2023 May 26. doi: 10.1007/s00432-023-04810.
    PubMed    
    Abstract available

  51. ZHANG S, Jin G, Ding F, Zhang J, et al
    A case of endocervical adenocarcinoma of the gastric type that was repeatedly misdiagnosed: A case report and literature review.
    Medicine (Baltimore). 2023;102:e33682.
    PubMed    
    Abstract available

  52. ZHANG Y, Wang H, Lu J, Lv Q, et al
    Down-regulation of S1PR2 is correlated with poor prognosis and immune infiltrates in cervical squamous cell carcinoma and endocervical adenocarcinoma.
    Int J Immunopathol Pharmacol. 2023;37:3946320231178131.
    PubMed    
    Abstract available

  53. SU SY
    Mortality trends and disease burdens of cervical, endometrial and ovarian cancers from 1981 to 2020 in Taiwan.
    Prev Med. 2023;172:107551.
    PubMed    
    Abstract available

  54. VAITSES FONTANARI AM, Bauer GR, Churchill SM, Brandelli Costa A, et al
    Gynecological Care Among Brazilian Women Who Have Sex with Women: A Respondent-Driven Sampling Study.
    LGBT Health. 2023;10:287-295.
    PubMed    
    Abstract available

  55. ROHRICH M
    Fibroblast Activation Protein Inhibitor PET Imaging in Head and Neck Cancer.
    PET Clin. 2023;18:315-323.
    PubMed    
    Abstract available

  56. INCE O, Uysal E, Durak G, Onol S, et al
    Prediction of carcinogenic human papillomavirus types in cervical cancer from multiparametric magnetic resonance images with machine learning-based radiomics models.
    Diagn Interv Radiol. 2023;29:460-468.
    PubMed    
    Abstract available

  57. MATSUMOTO T, Suzuki T, Nakamura M, Yamamoto M, et al
    Androgen promotes squamous differentiation of atypical cells in cervical intraepithelial neoplasia via an ELF3-dependent pathway.
    Cancer Med. 2023;12:10816-10828.
    PubMed    
    Abstract available

  58. TSAI YH, Teng YT, Kuan TC, Liu JJ, et al
    Five-year Survival Trends for Young Adult Cancers Diagnosed from 2002 to 2014 in Taiwan and the United States.
    Cancer Epidemiol Biomarkers Prev. 2023;32:834-839.
    PubMed    
    Abstract available

  59. WANG JC, Peitzmeier S, Reisner SL, Deutsch MB, et al
    Factors Associated with Unsatisfactory Pap Tests Among Sexually Active Trans Masculine Adults.
    LGBT Health. 2023;10:278-286.
    PubMed    
    Abstract available

  60. XU M, Jiang T
    First report of successful treatment of cervical lymph node metastasis with irreversible electroporation.
    QJM. 2023;116:385-387.
    PubMed    


  61. GHANAAT M, Kaboosi H, Negahdari B, Fattahi E, et al
    Heterologous Prime-boost Vaccination Using Adenovirus and Albumin Nanoparticles as Carriers for Human Papillomavirus 16 E7 Epitope.
    Curr Pharm Biotechnol. 2023;24:1195-1203.
    PubMed    
    Abstract available

  62. KUSAKABE M, Taguchi A, Sone K, Mori M, et al
    Carcinogenesis and management of human papillomavirus-associated cervical cancer.
    Int J Clin Oncol. 2023 Jun 9. doi: 10.1007/s10147-023-02337.
    PubMed    
    Abstract available

  63. BOLON J, Samson A, Irwin N, Murray L, et al
    An audit of adherence to cervical cancer screening guidelines in a tertiary-level HIV clinic.
    South Afr J HIV Med. 2023;24:1490.
    PubMed    
    Abstract available

  64. PATEL L, Deng Z, Zhu Z, Lequio M, et al
    Olive: A Potential Suppressor for Cervical Cancer by Upregulation of P21.
    Cureus. 2023;15:e38719.
    PubMed    
    Abstract available

  65. ZHANG Y, Li X, Zhang J, Mao L, et al
    Development and Validation of the Promising PPAR Signaling Pathway-Based Prognostic Prediction Model in Uterine Cervical Cancer.
    PPAR Res. 2023;2023:4962460.
    PubMed    
    Abstract available

  66. OIKE T, Osu N, Yoshimoto Y, Obinata H, et al
    Pilot study of plasma creatine riboside as a potential biomarker for cervical cancer.
    Heliyon. 2023;9:e16684.
    PubMed    
    Abstract available

  67. LIAO D, Liu Y, Li C, He B, et al
    Arctigenin hinders the invasion and metastasis of cervical cancer cells via the FAK/paxillin pathway.
    Heliyon. 2023;9:e16683.
    PubMed    
    Abstract available

  68. HISHINUMA E, Shimada M, Matsukawa N, Li B, et al
    Identification of predictive biomarkers for diagnosis and radiation sensitivity of uterine cervical cancer using wide-targeted metabolomics.
    J Obstet Gynaecol Res. 2023 Jun 9. doi: 10.1111/jog.15709.
    PubMed    
    Abstract available

  69. MATOS AS, Invencao MDCV, Moura IA, Freitas AC, et al
    Immunoinformatics applications in the development of therapeutic vaccines against human papillomavirus-related infections and cervical cancer.
    Rev Med Virol. 2023 Jun 8:e2463. doi: 10.1002/rmv.2463.
    PubMed    
    Abstract available

  70. ZHANG Y, Fan S, Shan M, Zou W, et al
    Propensity score matching analysis to comparing cisplatin versus nedaplatin based doublet agent concurrent chemoradiotherapy for locally advanced cervical cancer.
    Sci Rep. 2023;13:9352.
    PubMed    
    Abstract available

  71. ZHANG W, Ruan Y, Ye L, Liu M, et al
    Definite chemoradiotherapy for early-stage "bulky" cervical cancer.
    J Formos Med Assoc. 2023 Jun 6:S0929-6646(23)00204.
    PubMed    


  72. CHINTALA S, Dankoski MA, Anbarasu A, Ramaiah S, et al
    NFX1-123: A potential therapeutic target in cervical cancer.
    J Med Virol. 2023;95:e28856.
    PubMed    
    Abstract available

  73. YANG L, Tao H, Lin B, He X, et al
    Utilization of PAX1 methylation test for cervical cancer screening of non-HPV16/18 high-risk HPV infection in women.
    Future Oncol. 2023 Jun 8. doi: 10.2217/fon-2023-0226.
    PubMed    
    Abstract available

  74. ZHANG M, Sit JWH, Choi KC, Chan CWH, et al
    A theory-driven, culture-tailored educational intervention for cervical cancer screening among rural Chinese females: A feasibility and pilot study.
    Asia Pac J Oncol Nurs. 2023;10:100218.
    PubMed    
    Abstract available

  75. RANGEL V, Fernandez-Deaza GP, Castillo JS, Murillo R, et al
    Is it feasible to enhance quality assurance of cervical cancer screening in Latin America? A regional expert consensus.
    J Med Screen. 2023 Jun 8:9691413231178253. doi: 10.1177/09691413231178253.
    PubMed    
    Abstract available

  76. LI C, Liu D, Zhao Y, Ding Y, et al
    Diverse intratumoral heterogeneity and immune microenvironment of two HPV-related cervical cancer types revealed by single-cell RNA sequencing.
    J Med Virol. 2023;95:e28857.
    PubMed    
    Abstract available

  77. SINGH A, Mani N, Aggarwal LM, Agarwal S, et al
    Dose at posterior-inferior border of symphysis point: A predictor for vaginal stricture in cervical cancer.
    Brachytherapy. 2023 Jun 5:S1538-4721(23)00053.
    PubMed    
    Abstract available

  78. ZHANG L, Li WP
    Retraction notice to "New Cu(II) coordination polymer inhibits cervical cancer development by regulating BRCA1 protein via miR-9-5p" [J. Inorg. Biochem. 226 (2022) 111655].
    J Inorg Biochem. 2023 Jun 5:112270. doi: 10.1016/j.jinorgbio.2023.112270.
    PubMed    


  79. ZHANG Z, Peng J, Li B, Wang Z, et al
    HOXA1 promotes aerobic glycolysis and cancer progression in cervical cancer.
    Cell Signal. 2023 Jun 5:110747. doi: 10.1016/j.cellsig.2023.110747.
    PubMed    
    Abstract available

  80. TSONEVA E, Dimitrova PD, Metodiev M, Shivarov V, et al
    The effects of ROMO1 on cervical cancer progression.
    Pathol Res Pract. 2023;248:154561.
    PubMed    
    Abstract available

  81. MAO L, Zhang X, Chen T, Li Z, et al
    High-resolution reduced field-of-view diffusion-weighted magnetic resonance imaging in the diagnosis of cervical cancer.
    Quant Imaging Med Surg. 2023;13:3464-3476.
    PubMed    
    Abstract available

  82. SHEN M, Zou Z, Bao H, Fairley CK, et al
    Cost-effectiveness of artificial intelligence-assisted liquid-based cytology testing for cervical cancer screening in China.
    Lancet Reg Health West Pac. 2023;34:100726.
    PubMed    
    Abstract available

  83. KOUSAR K, Naseer F, Abduh MS, Anjum S, et al
    CD44 targeted delivery of oncolytic Newcastle disease virus encapsulated in thiolated chitosan for sustained release in cervical cancer: a targeted immunotherapy approach.
    Front Immunol. 2023;14:1175535.
    PubMed    
    Abstract available

  84. ZHOU J, Mo J, Tan C, Xie F, et al
    JUND Promotes Tumorigenesis via Specifically Binding on Enhancers of Multiple Oncogenes in Cervical Cancer.
    Onco Targets Ther. 2023;16:347-357.
    PubMed    
    Abstract available

  85. LI T, Chen S, Li X, Wu Z, et al
    The features of high-risk human papillomavirus infection in different female genital sites and impacts on HPV-based cervical cancer screening.
    Virol J. 2023;20:116.
    PubMed    
    Abstract available

  86. TONG Y, Tonui P, Orang'o O, Zhang J, et al
    Association of plasma aflatoxin with persistent detection of oncogenic human papillomaviruses in cervical samples from Kenyan women enrolled in a longitudinal study.
    BMC Infect Dis. 2023;23:377.
    PubMed    
    Abstract available

  87. HUNTINGTON S, Puri Sudhir K, Schneider V, Sargent A, et al
    Two self-sampling strategies for HPV primary cervical cancer screening compared with clinician-collected sampling: an economic evaluation.
    BMJ Open. 2023;13:e068940.
    PubMed    
    Abstract available

  88. MA Y, Yang Z, Liu J, Wang D, et al
    CD48 suppresses cell proliferation and migration as a prognostic immune signature in the cervical cancer immune microenvironment.
    Carcinogenesis. 2023 Jun 3:bgad039. doi: 10.1093.
    PubMed    
    Abstract available

  89. PHUNG MT, An PL, Vinh NN, Le HHTC, et al
    A comparative study on behavior, awareness and belief about cervical cancer among rural and urban women in Vietnam.
    PLOS Glob Public Health. 2023;3:e0001817.
    PubMed    
    Abstract available

  90. BAETEN IGT, Hoogendam JP, Braat AJAT, de Keizer B, et al
    Learning curve and factors influencing successful robot-assisted bilateral sentinel lymph node mapping in early-stage cervical cancer: an observational cohort study.
    Expert Rev Med Devices. 2023 Jun 5:1-8. doi: 10.1080/17434440.2023.2212157.
    PubMed    
    Abstract available

  91. BURCHARDT E, Bos-Liedke A, Serkowska K, Cegla P, et al
    Value of [(18)F]FDG PET/CT radiomic parameters in the context of response to chemotherapy in advanced cervical cancer.
    Sci Rep. 2023;13:9092.
    PubMed    
    Abstract available

  92. BOWDEN SJ, Ellis LB, Kalliala I, Paraskevaidi M, et al
    Protocol for a systematic review and meta-analysis of the diagnostic test accuracy of host and HPV DNA methylation in cervical cancer screening and management.
    BMJ Open. 2023;13:e071534.
    PubMed    
    Abstract available

  93. MKUU R, Salloum RG, Shenkman E, Schaefer N, et al
    Screening for cervical cancer among women with behavioral health conditions-A systematic review.
    Prev Med Rep. 2023;34:102238.
    PubMed    
    Abstract available

  94. ZHANG H, Wang J, Yang J, He Q, et al
    TMEM33 as a Prognostic Biomarker of Cervical Cancer and Its Correlation with Immune Infiltration.
    Mediators Inflamm. 2023;2023:5542181.
    PubMed    
    Abstract available

  95. YU B, Li X, Yan W, Ding B, et al
    Post-transcriptional regulation of tumor suppressor gene lncRNA CARMN via m(6)A modification and miRNA regulation in cervical cancer.
    J Cancer Res Clin Oncol. 2023 Jun 5. doi: 10.1007/s00432-023-04893.
    PubMed    
    Abstract available

  96. SUN J, Mou J, Zhang Y, Yuan K, et al
    Matrix metalloproteinase-2 delivery to extracellular vesicles produced by HPV-positive cervical cancer cells enhances metastasis via the Akt pathway.
    Cell Biol Int. 2023 Jun 5. doi: 10.1002/cbin.12054.
    PubMed    
    Abstract available

  97. TANG Q, Xu A, Yang Y, Zhang Y, et al
    FOXM1 Contributes to Chemotherapy Sensitivity in Cervical Cancer by Regulating TTK.
    Discov Med. 2023;35:208-220.
    PubMed    
    Abstract available

  98. BADDAL B, Oktay MN, Bostanci A, Yenen MC, et al
    Prevalence and genotype screening of human papillomavirus among women attending a private hospital in Northern Cyprus: an 11-year retrospective study.
    BMC Womens Health. 2023;23:297.
    PubMed    
    Abstract available

  99. LV X, Ding B, Xu J, Shen Y, et al
    Effect of modified radical laparoscopic hysterectomy versus open radical hysterectomy on short-term clinical outcomes in early-stage cervical cancer: a single-center, prospective, randomized controlled trial.
    World J Surg Oncol. 2023;21:167.
    PubMed    
    Abstract available

  100. LIU P, Li Z, Miao J, Kong B, et al
    HPV DNA and p16(INK4a) positivity in vulvar cancer and vulvar intraepithelial neoplasia - Authors' reply.
    Lancet Oncol. 2023;24:e237.
    PubMed    


  101. JAYARAJ R, Shetty S, Gothandam KM, Suja S, et al
    HPV DNA and p16(INK4a) positivity in vulvar cancer and vulvar intraepithelial neoplasia.
    Lancet Oncol. 2023;24:e236.
    PubMed    


  102. ANIL A, Shamim MA, Saravanan A, Sandeep M, et al
    HPV DNA and p16(INK4a) positivity in vulvar cancer and vulvar intraepithelial neoplasia.
    Lancet Oncol. 2023;24:e235.
    PubMed    


  103. CHU T, Meng Y, Wu P, Li Z, et al
    The prognosis of patients with small cell carcinoma of the cervix: a retrospective study of the SEER database and a Chinese multicentre registry.
    Lancet Oncol. 2023;24:701-708.
    PubMed    
    Abstract available

  104. MOSS EL, Teece L, Darko N
    Uterine cancer mortality and Black women: time to act.
    Lancet Oncol. 2023;24:586-588.
    PubMed    


  105. APPIAH EO, Oti-Boadi E, Appiah S, Bakkari MA, et al
    Acceptance of HPV vaccination in boys among mothers from selected churches in Accra, Ghana.
    BMC Public Health. 2023;23:1053.
    PubMed    
    Abstract available

  106. ZHANG H, Xiang W, Ji ST, Xiao YP, et al
    [Clinicopathological analysis of primary gastric (gastrointestinal)-type mucoglandular lesion of endometrium].
    Zhonghua Bing Li Xue Za Zhi. 2023;52:586-591.
    PubMed    
    Abstract available

  107. EBRAHIMI N, Yousefi Z, Khosravi G, Malayeri FE, et al
    Human papillomavirus vaccination in low- and middle-income countries: progression, barriers, and future prospective.
    Front Immunol. 2023;14:1150238.
    PubMed    
    Abstract available

  108. LIU Y, Li Z, Yuan L, Liu F, et al
    Human papillomavirus genotypic characteristics of 60,685 subjects under age-expansion vaccination of the nine-valent human papillomavirus vaccine: A cross-sectional study.
    J Infect Public Health. 2023;16:989-995.
    PubMed    
    Abstract available


  109. Many Unaware of Link between HPV and Some Cancers.
    Cancer Discov. 2023;13:OF4.
    PubMed    
    Abstract available

  110. MALLAFRE-LARROSA M, Ritchie D, Papi G, Mosquera I, et al
    Survey of current policies towards widening cervical screening coverage among vulnerable women in 22 European countries.
    Eur J Public Health. 2023;33:502-508.
    PubMed    
    Abstract available

  111. BARR E, Noursi S, Roodzant E, Ubesie A, et al
    Public Priorities in Women's Health: Analysis of Request for Information Published to Inform "Advancing NIH Research on the Health of Women: A 2021 Conference".
    J Womens Health (Larchmt). 2023;32:625-634.
    PubMed    
    Abstract available

  112. KESKE A, Weisman PS, Xu J
    Adenosquamous carcinoma in situ of the anus: a case series.
    Virchows Arch. 2023;482:993-997.
    PubMed    
    Abstract available

  113. PARADA H JR, Pichardo MS, Gallo LC, Talavera GA, et al
    Neurocognitive test performance following cancer among middle-aged and older adults in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL) and the SOL-Investigation of Neurocognitive Aging Ancillary Study.
    Cancer Med. 2023;12:11860-11870.
    PubMed    
    Abstract available

  114. CLIFFORD GM, Baussano I, Heideman DAM, Tshering S, et al
    Human papillomavirus testing on self-collected samples to detect high-grade cervical lesions in rural Bhutan: The REACH-Bhutan study.
    Cancer Med. 2023;12:11828-11837.
    PubMed    
    Abstract available

  115. NUTTALL DS, Anderson WJ, Savage AJ, Denton K, et al
    Calibration of the Becton Dickinson FocalPoint GS slide profiler is essential for optimal performance: Avoiding the algorithm supersaturation cascade effect pitfall.
    Cancer Cytopathol. 2023;131:383-391.
    PubMed    
    Abstract available

  116. WANG W, Zhang N
    Oridonin inhibits Hela cell proliferation via downregulation of glutathione metabolism: a new insight from metabolomics.
    J Pharm Pharmacol. 2023;75:837-845.
    PubMed    
    Abstract available

  117. SCHURINK-VAN 'T KLOOSTER TM, Siebers AG, Hoes J, van Kemenade FJ, et al
    Early effect of bivalent human papillomavirus vaccination on cytology outcomes in cervical samples among young women in the Netherlands.
    Cancer Med. 2023;12:11786-11794.
    PubMed    
    Abstract available

  118. TENG X, Kang S, Li W, Ding H, et al
    Comparison between laparoscopic and abdominal radical hysterectomy for cervical adenosquamous carcinoma at stage IA2 to IIA2: A multicenter retrospective study.
    J Obstet Gynaecol Res. 2023;49:1592-1610.
    PubMed    
    Abstract available

  119. PERSONS P, Long M, Vegunta S
    Latent Human Papillomavirus (HPV) Infection: Does HPV Last Forever in Some Women?
    J Womens Health (Larchmt). 2023;32:623-624.
    PubMed    


  120. NELSON CW, Mirabello L
    Human papillomavirus genomics: Understanding carcinogenicity.
    Tumour Virus Res. 2023;15:200258.
    PubMed    
    Abstract available

  121. VELENTZIS LS, Hawkes D, Caruana M, Brotherton JM, et al
    Exploring monitoring strategies for population surveillance of HPV vaccine impact using primary HPV screening.
    Tumour Virus Res. 2023;15:200255.
    PubMed    
    Abstract available

  122. ZHANG X, Elsaid MI, DeGraffinreid C, Champion VL, et al
    Impact of the COVID-19 Pandemic on Cancer Screening Delays.
    J Clin Oncol. 2023;41:3194-3202.
    PubMed    
    Abstract available

  123. ONYEAKA HK, Muoghalu C, Deary EC, Ajayi KV, et al
    The Role of Health Information Technology in Improving Awareness of Human Papillomavirus and Human Papillomavirus Vaccine Among U.S. Adults.
    Telemed J E Health. 2023;29:886-895.
    PubMed    
    Abstract available

  124. CARTWRIGHT K, Leekity S, Sheche J, Kanda D, et al
    Health Literacy, Health Numeracy, and Cancer Screening Patterns in the Zuni Pueblo: Insights from and Limitations of "Standard" Questions.
    J Cancer Educ. 2023;38:1023-1033.
    PubMed    
    Abstract available

  125. BRITO MJ, Quintas A, Passos F, Alves AT, et al
    Lymphocyte Subsets in Cervicovaginal Lavage Specimens of HIV-Infected Women: A Surrogate Risk Marker of HPV-Associated Cervical Lesions.
    Pathobiology. 2023;90:176-186.
    PubMed    
    Abstract available

  126. THANASUWAT B, Leung SOA, Welch K, Duffey-Lind E, et al
    Human Papillomavirus (HPV) Education and Knowledge Among Medical and Dental Trainees.
    J Cancer Educ. 2023;38:971-976.
    PubMed    
    Abstract available

  127. CHAU JPC, Lo SHS, Butt L, Lee VWY, et al
    User Engagement on a Novel Educational Health Intervention Aimed at Increasing HPV Vaccine Uptake in Hong Kong: a Qualitative Study.
    J Cancer Educ. 2023;38:772-780.
    PubMed    
    Abstract available

  128. HUANG XD, Chen K, Shi L, Luo YS, et al
    Construction of refined staging classification systems integrating FIGO/T-categories and corpus uterine invasion for non-metastatic cervical cancer.
    Cancer Med. 2023 Jun 16. doi: 10.1002/cam4.6179.
    PubMed    
    Abstract available

  129. BOLANOS-SUAREZ V, Alfaro A, Espinosa AM, Medina-Martinez I, et al
    The mRNA and protein levels of the glycolytic enzymes lactate dehydrogenase A (LDHA) and phosphofructokinase platelet (PFKP) are good predictors of survival time, recurrence, and risk of death in cervical cancer patients.
    Cancer Med. 2023 Jun 16. doi: 10.1002/cam4.6123.
    PubMed    
    Abstract available

  130. SHEN NN, Lin JH, Liu PP
    [EBF1 Promotes the Sensitivity of Cervical Cancer Cells to Cisplatin via Activating FBN1 Transcription].
    Mol Biol (Mosk). 2023;57:503-504.
    PubMed    
    Abstract available

  131. ZHAO M, Gao Z, Gu X, Yang X, et al
    Predictive significance of lymphocyte level and neutrophil-to-lymphocyte ratio values during radiotherapy in cervical cancer treatment.
    Cancer Med. 2023 Jun 16. doi: 10.1002/cam4.6221.
    PubMed    
    Abstract available

  132. SHI YY, Wang AJ, Liu XL, Dai MY, et al
    Stapled peptide PROTAC induced significantly greater anti-PD-L1 effects than inhibitor in human cervical cancer cells.
    Front Immunol. 2023;14:1193222.
    PubMed    
    Abstract available

  133. ADUMALA A, Palat G, Vajjala A, Brun E, et al
    Oral Methadone versus Morphine IR for Patients with Cervical Cancer and Neuropathic Pain: A Prospective Randomised Controlled Trial.
    Indian J Palliat Care. 2023;29:200-206.
    PubMed    
    Abstract available


  134. CCDC7 Activates Interleukin-6 and Vascular Endothelial Growth Factor to Promote Proliferation via the JAK-STAT3 Pathway in Cervical Cancer Cells [Retraction].
    Onco Targets Ther. 2023;16:407-408.
    PubMed    
    Abstract available

  135. LIU L, Li L, Zu W, Jing J, et al
    PIWI-interacting RNA-17458 is oncogenic and a potential therapeutic target in cervical cancer.
    J Cancer. 2023;14:1648-1659.
    PubMed    
    Abstract available

  136. LI L, Shen FR, Cheng Q, Sun J, et al
    SLC5A3 is important for cervical cancer cell growth.
    Int J Biol Sci. 2023;19:2787-2802.
    PubMed    
    Abstract available

  137. OTANI T, Miyake KK, Ishimori T, Kido A, et al
    Prognostic value of pretreatment FDG PET/CT in uterine cervical cancer according to two major histologic types: squamous cell carcinoma and adenocarcinoma.
    Asia Ocean J Nucl Med Biol. 2023;11:101-110.
    PubMed    
    Abstract available

  138. BHAGAVATHULA AS, Bansil S, Nishimura Y
    Google Trends in Breast and Cervical Cancer Searches From 2008 to 2021: An Infodemiology Study.
    Cureus. 2023;15:e39035.
    PubMed    
    Abstract available

  139. IIDA Y, Osaki M, Sato S, Izutsu R, et al
    AMIGO2 expression as a predictor of recurrence in cervical cancer with intermediate risk.
    Mol Clin Oncol. 2023;19:56.
    PubMed    
    Abstract available

  140. DE WAARD J, Bhattacharya A, de Boer MT, van Hemel BM, et al
    Identification of a methylation panel as an alternative triage to detect CIN3+ in hrHPV-positive self-samples from the population-based cervical cancer screening programme.
    Clin Epigenetics. 2023;15:103.
    PubMed    
    Abstract available

  141. TORII A, Tomita N, Kuno M, Nishio M, et al
    Intensity-modulated radiation therapy with the central shielding technique for patients with uterine cervical cancerdagger.
    J Radiat Res. 2023 Jun 15:rrad039. doi: 10.1093.
    PubMed    
    Abstract available

  142. ZHU M, Zhuo Q, Liu W, Guan C, et al
    Imaging evaluation of para-aortic lymph nodes in cervical cancer.
    Acta Radiol. 2023 Jun 15:2841851231179178. doi: 10.1177/02841851231179178.
    PubMed    
    Abstract available

  143. HU M, Jiang C, Meng R, Luo Y, et al
    Effect of air pollution on the prevalence of breast and cervical cancer in China: a panel data regression analysis.
    Environ Sci Pollut Res Int. 2023 Jun 15. doi: 10.1007/s11356-023-28068.
    PubMed    
    Abstract available

  144. AMBOREE TL, Parker SL, Bulsara S, Anderson ML, et al
    Cervical cancer screening among English- and Spanish-speaking Hispanic women in an urban safety net health system, 2015-2020.
    BMC Womens Health. 2023;23:309.
    PubMed    
    Abstract available

  145. TOMITA F, Fuse H, Fujisaki T, Yasue K, et al
    [Verification of Dose Distribution in Cervical Cancer Brachytherapy Using Metal and Plastic Applicators].
    Nihon Hoshasen Gijutsu Gakkai Zasshi. 2023 Jun 14. doi: 10.6009/jjrt.2023-1375.
    PubMed    
    Abstract available

  146. APPIAH EO, Appiah S, Ani-Amponsah M, Agyekum BS, et al
    Female students' perspectives on cervical cancer screening inclusion in pre-admission university requirements in Ghana.
    PLOS Glob Public Health. 2023;3:e0001029.
    PubMed    
    Abstract available

  147. GHAFOOR S
    Editorial Comment: On the Contemporary Role of MRI and FDG PET/CT in Managing Cervical Cancer.
    AJR Am J Roentgenol. 2023 Jun 14. doi: 10.2214/AJR.23.29755.
    PubMed    


  148. WU Y, Min L, Zhang P, Zhang L, et al
    ORP5 promotes migration and invasion of cervical cancer cells by inhibiting endoplasmic reticulum stress.
    Cell Stress Chaperones. 2023 Jun 14. doi: 10.1007/s12192-023-01357.
    PubMed    
    Abstract available

  149. JAGGI VK, Ansari MA, Khanna A, Gehlot S, et al
    Is postoperative radiotherapy (PORT) a viable option in high-risk early-stage cervical cancer after upfront or downstaged radical surgery? A comparative study.
    J Cancer Res Ther. 2023;19:241-252.
    PubMed    
    Abstract available

  150. EL KHOURY J, Halabi R, Hleyhel M, El Rahman Kishly W, et al
    HPV Vaccination Prevalence among Lebanese Female University Students: A Cross-Sectional Study.
    J Environ Public Health. 2023;2023:3706466.
    PubMed    
    Abstract available

  151. KAKALIASHVILI-DZAGNIDZE S, Khardzeishvili O, Tabagari S
    Diagnostic Accuracy of p16(INK4a)/Ki-67 Dual Immunostaining for Detection of High-Grade Cervical Intraepithelial Neoplasia in Women Involved in Cervical Cancer Screening in Georgia.
    Anal Cell Pathol (Amst). 2023;2023:7988323.
    PubMed    
    Abstract available

  152. ZHANG S, Chen Z, Sun J, An N, et al
    Retraction Note: circRNA hsa_circRNA_0000069 promotes the proliferation, migration and invasion of cervical cancer through miR-873-5p/TUSC3 axis.
    Cancer Cell Int. 2023;23:115.
    PubMed    


  153. KRISHNA A, Sathya M, Mukesh S, Athiyamaan MS, et al
    Efficacy and safety of EGFR inhibitor gefitinib in recurrent or metastatic cervical cancer: a preliminary report.
    Med Oncol. 2023;40:203.
    PubMed    
    Abstract available

  154. WANG X, Cao C, Tan X, Liao X, et al
    SETD8, a frequently mutated gene in cervical cancer, enhances cisplatin sensitivity by impairing DNA repair.
    Cell Biosci. 2023;13:107.
    PubMed    
    Abstract available

  155. NETO BV, Tavares V, da Silva JB, Liz-Pimenta J, et al
    Thrombogenesis-associated genetic determinants as predictors of thromboembolism and prognosis in cervical cancer.
    Sci Rep. 2023;13:9519.
    PubMed    
    Abstract available

  156. SUBA EJ, Donnelly AD, Duong DV, Gonzalez Mena LE, et al
    WHO should adjust its global strategy for cervical cancer prevention.
    BMJ Glob Health. 2023;8:e012031.
    PubMed    


  157. IBANEZ R, Roura E, Acera A, Andujar M, et al
    HPV self-sampling among cervical cancer screening users in Spain: A randomized clinical trial of on-site training to increase the acceptability.
    Prev Med. 2023 Jun 10:107571. doi: 10.1016/j.ypmed.2023.107571.
    PubMed    
    Abstract available

  158. YOU S, Zhang J, Yu L, Li Z, et al
    Construction of SLC16A1/3 Targeted Gallic Acid-Iron-Embelin Nanoparticles for Regulating Glycolysis and Redox Pathways in Cervical Cancer.
    Mol Pharm. 2023 Jun 12. doi: 10.1021/acs.molpharmaceut.3c00294.
    PubMed    
    Abstract available

  159. ADAM JA, Poel E, van Eck-Smit BLF, Mom CH, et al
    Lymphatic mapping for image-guided radiotherapy in patients with locally advanced uterine cervical cancer: a feasibility study.
    EJNMMI Res. 2023;13:58.
    PubMed    
    Abstract available

  160. WANG Y, Yuan S, Ma J, Liu H, et al
    WIF1 was downregulated in cervical cancer due to promoter methylation.
    Acta Biochim Pol. 2023 Jun 12. doi: 10.18388/abp.2020_6700.
    PubMed    
    Abstract available

  161. WANG A, Jin C, Wang Y, Yu J, et al
    FTO promotes the progression of cervical cancer by regulating the N6-methyladenosine modification of ZEB1 and Myc.
    Mol Carcinog. 2023 Jun 12. doi: 10.1002/mc.23559.
    PubMed    
    Abstract available

  162. GULER OC, Oymak E, Yazici G, Akagunduz OO, et al
    Multi-institutional analysis of cervical esophageal carcinoma patients treated with definitive chemoradiotherapy: TROD 01-005 study.
    Oncol Res. 2023;31:299-306.
    PubMed    
    Abstract available

  163. LIU YY, Zhu WH, Li W, Hao X, et al
    Identifying the risk factors and developing a predictive model for postoperative pelvic floor dysfunction in cervical cancer patients.
    Transl Cancer Res. 2023;12:1307-1314.
    PubMed    
    Abstract available

  164. GREENLEY R, Bell S, Rigby S, Legood R, et al
    Factors influencing the participation of groups identified as underserved in cervical cancer screening in Europe: a scoping review of the literature.
    Front Public Health. 2023;11:1144674.
    PubMed    
    Abstract available

  165. DURU G, Topatan S
    A barrier to participation in cervical cancer screenings: fatalism.
    Women Health. 2023 Jun 11:1-9. doi: 10.1080/03630242.2023.2223698.
    PubMed    
    Abstract available

  166. LI F, Zhu W
    LINC00460 promotes angiogenesis by enhancing NF-kappaB-mediated VEGFA expression in cervical cancer cells.
    Biochem Biophys Res Commun. 2023;671:146-152.
    PubMed    
    Abstract available

  167. CHEN H, Xie H, Zhang Y, Wang G, et al
    Construction of a prognostic signature of RFC5 immune-related genes in patients with cervical cancer.
    Cancer Biomark. 2023 May 24. doi: 10.3233/CBM-220347.
    PubMed    
    Abstract available

  168. GOKHALE M, Yu R, Monberg M, Tekin C, et al
    Patient profiles, treatment patterns, and outcomes among persistent, recurrent, or metastatic cervical cancer patients under routine care in the United States.
    Cancer Treat Res Commun. 2023;36:100726.
    PubMed    
    Abstract available

  169. SUN X, Chen Y, Zhong Y, Chen X, et al
    Recently urodynamic and quality of life assessment in the non-menopausal women with cervical cancer after radical hysterectomy.
    Support Care Cancer. 2023;31:389.
    PubMed    
    Abstract available

  170. ZHANG R, Hong G, Liao C, Chen Z, et al
    High-risk Human Papillomavirus Infection in Putian, China: A Cross-sectional Analysis of 98085 Women.
    J Coll Physicians Surg Pak. 2023;33:642-646.
    PubMed    
    Abstract available

  171. BAYALA B, Coulibaly LL, Djigma F, Bunay J, et al
    Chemical Composition of Essential Oil of Cymbopogon schoenanthus (L.) Spreng from Burkina Faso, and Effects against Prostate and Cervical Cancer Cell Lines.
    Molecules. 2023;28:4561.
    PubMed    
    Abstract available

  172. YANG Z, Liu ZY, Ablise M, Maimaiti A, et al
    Design, Synthesis, and Anti-Cervical Cancer and Reversal of Tumor Multidrug Resistance Activity of Novel Nitrogen-Containing Heterocyclic Chalcone Derivatives.
    Molecules. 2023;28:4537.
    PubMed    
    Abstract available

  173. WANG M, Chen X, Qu Y, Ma Q, et al
    Design and Synthesis of Brefeldin A-Isothiocyanate Derivatives with Selectivity and Their Potential for Cervical Cancer Therapy.
    Molecules. 2023;28:4284.
    PubMed    
    Abstract available

  174. KNIAZEVA M, Zabegina L, Shalaev A, Smirnova O, et al
    NOVAprep-miR-Cervix: New Method for Evaluation of Cervical Dysplasia Severity Based on Analysis of Six miRNAs.
    Int J Mol Sci. 2023;24:9114.
    PubMed    
    Abstract available

  175. NYABIGAMBO A, Mayega RW, Hlongwana K, Ginindza TG, et al
    Facilitators and Barriers to HPV Self-Sampling as a Cervical Cancer Screening Option among Women Living with HIV in Rural Uganda.
    Int J Environ Res Public Health. 2023;20:6004.
    PubMed    
    Abstract available

  176. CHEN CS, Huang EY
    Comparison of Oncologic Outcomes between Radical Hysterectomy and Primary Concurrent Chemoradiotherapy in Women with Bulky IB and IIA Cervical Cancer under Risk Stratification.
    Cancers (Basel). 2023;15:3034.
    PubMed    
    Abstract available

  177. DISIS ML, Adams SF, Bajpai J, Butler MO, et al
    Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gynecologic cancer.
    J Immunother Cancer. 2023;11:e006624.
    PubMed    
    Abstract available

  178. SIDDIQUI G, Zara Rozalen A, Nava VE
    Androgen receptor amplification in mesonephric remnants.
    BMJ Case Rep. 2023;16:e251741.
    PubMed    
    Abstract available

  179. FAN Z, Wu X, Li C, Chen H, et al
    CAM-VT: A Weakly supervised cervical cancer nest image identification approach using conjugated attention mechanism and visual transformer.
    Comput Biol Med. 2023;162:107070.
    PubMed    
    Abstract available

  180. DAVIES L, Milner DA Jr, Shulman LN, Kyokunda L, et al
    Analysis of Cancer Research Projects in Sub-Saharan Africa: A Quantitative Perspective on Unmet Needs and Opportunities.
    JCO Glob Oncol. 2023;9:e2200203.
    PubMed    
    Abstract available

  181. LIU J, Wang C, Ma J, Wei S, et al
    Pattern of infection and genotypes of human papillomavirus in Zhengzhou City based on a four-year (2015-2018) epidemiological study.
    Women Health. 2023;63:383-391.
    PubMed    
    Abstract available

  182. SONG J, Xu F, An L, Yin Y, et al
    BTG2 suppresses the growth and metastasis of cervical squamous cell carcinoma.
    Pathol Res Pract. 2023;247:154577.
    PubMed    
    Abstract available

  183. JIA Q, Wang H, Xiao X, Sun Y, et al
    UCHL1 acts as a prognostic factor and promotes cancer stemness in cervical squamous cell carcinoma.
    Pathol Res Pract. 2023;247:154574.
    PubMed    
    Abstract available

  184. MELKONIAN SC, Chen L, Jim MA, Haverkamp D, et al
    Disparities in incidence and trends of colorectal, lung, female breast, and cervical cancers among non-Hispanic American Indian and Alaska Native people, 1999-2018.
    Cancer Causes Control. 2023;34:657-670.
    PubMed    
    Abstract available

  185. ROMAN DE METTELINGE T, Desimpelaere P, Cambier D
    Cervical mobility and cervical proprioception in relation to fall risk among older adults: a prospective cohort study.
    Eur Geriatr Med. 2023;14:447-453.
    PubMed    
    Abstract available

  186. ELLIS SDP, Kenney-Herbert E, Crosby T, Mukherjee S, et al
    Cervical Oesophageal Cancer: A Call for Treatment Consensus.
    Clin Oncol (R Coll Radiol). 2023;35:478-481.
    PubMed    


  187. MANZ CR, Odayar VS, Schrag D
    Cancer Screening Rates and Outcomes for Justice-Involved Individuals: A Scoping Review.
    J Correct Health Care. 2023;29:220-231.
    PubMed    
    Abstract available

  188. SEGAL HA, Rashid N
    A targeted literature review of health economic analyses of human papillomavirus vaccination from various countries.
    Int J STD AIDS. 2023;34:512-517.
    PubMed    
    Abstract available

  189. ROUSSET-JABLONSKI C, Mekki Y, Denis A, Reynaud Q, et al
    Human papillomavirus prevalence, persistence and cervical dysplasia in females with cystic fibrosis.
    J Cyst Fibros. 2023;22:505-514.
    PubMed    
    Abstract available

  190. TSAO-WU L, Chepkorir J, Han HR
    Factors associated with HPV vaccination decision-making among Korean American women.
    J Behav Med. 2023;46:509-516.
    PubMed    
    Abstract available

  191. CAEIRO V, Esteves B, Fonseca-Moutinho J
    HPV testing for cervical cancer screening: Should reflex cytology be performed after a positive test for HPV 16 and 18?
    Cancer Treat Res Commun. 2023;36:100729.
    PubMed    
    Abstract available

  192. HIRAI R, Ohta T, Igari M, Kumazaki YU, et al
    Optimal Number of Needle Applicators Inserted in Combined Intracavitary and Interstitial Brachytherapy for Cervical Cancer.
    Anticancer Res. 2023;43:3265-3271.
    PubMed    
    Abstract available

  193. DENG Y, Song Y, Du Q, Wang CC, et al
    Anti-HPV16 oncoproteins siRNA therapy for cervical cancer using a novel transdermal peptide PKU12.
    Front Oncol. 2023;13:1175958.
    PubMed    
    Abstract available

  194. QIU J, Sun S, Liu Q, Fu J, et al
    A comparison of concurrent chemoradiotherapy and radical surgery in patients with specific locally advanced cervical cancer (stage IB3, IIA2, IIICr): trial protocol for a randomized controlled study (C-CRAL trial).
    J Gynecol Oncol. 2023 Jun 20. doi: 10.3802/jgo.2023.
    PubMed    
    Abstract available

  195. CHEN L, Lu F, Wang Z, Chen H, et al
    An investigation on cervical cancer and human papillomavirus vaccine knowledge, and analysis of influencing factors for choosing domestic or imported 2vHPV vaccine among females in Shenzhen, China.
    Hum Vaccin Immunother. 2023 Jun 23:2225389. doi: 10.1080/21645515.2023.2225389.
    PubMed    
    Abstract available

  196. MATSUMURA M, Seyama Y, Ogawa R, Nemoto S, et al
    Combined thoraco-laparoscopic hepatectomy concomitant with resection of the diaphragm for solitary peritoneal seeding from cervical cancer: A case report.
    Asian J Endosc Surg. 2023 Jun 22. doi: 10.1111/ases.13219.
    PubMed    
    Abstract available

  197. MEKURIA SF, Timmermans S, Borgfeldt C, Jerkeman M, et al
    HPV self-sampling versus healthcare provider collection on the effect of cervical cancer screening uptake and costs in LMIC: a systematic review and meta-analysis.
    Syst Rev. 2023;12:103.
    PubMed    
    Abstract available

  198. RODRIGUES M, Vanoni G, Loap P, Dubot C, et al
    Nivolumab plus chemoradiotherapy in locally-advanced cervical cancer: the NICOL phase 1 trial.
    Nat Commun. 2023;14:3698.
    PubMed    
    Abstract available

  199. CHEN H, Ma R, Zhou B, Yang X, et al
    Integrated immunological analysis of single-cell and bulky tissue transcriptomes reveals the role of interactions between M0 macrophages and naive CD4(+) T cells in the immunosuppressive microenvironment of cervical cancer.
    Comput Biol Med. 2023;163:107151.
    PubMed    
    Abstract available

  200. NAYAR R
    Cervical cancer prevention in the United States-where we've been and where we're going: The American Cancer Society Primary HPV Screening Initiative.
    Cancer Cytopathol. 2023 Jun 22. doi: 10.1002/cncy.22733.
    PubMed    


  201. DOWNS LS JR, Nayar R, Gerndt J, Saslow D, et al
    Implementation in action: Collaborating on the transition to primary HPV screening for cervical cancer in the United States.
    CA Cancer J Clin. 2023 Jun 22. doi: 10.3322/caac.21786.
    PubMed    


  202. AKPAN E, Abinya N, Odhiambo E, Ekpo E, et al
    Determinants of an integrated cervical cancer screening services in primary healthcare: sharing lessons from Kisumu, Kenya.
    J Public Health Afr. 2023;14:1783.
    PubMed    
    Abstract available

  203. RAUF SA, Zehra SA, Shah HH
    Beyond P16/Ki67 dual-stain cytology: Exploring alternative biomarkers for diagnosing cervical cancer and its precursors.
    BJOG. 2023 Jun 22. doi: 10.1111/1471-0528.17577.
    PubMed    


  204. TANG JH, Lee F, Chagomerana MB, Ghambi K, et al
    Results from Two HPV-Based Cervical Cancer Screening-Family Planning Integration Models in Malawi: A Cluster Randomized Trial.
    Cancers (Basel). 2023;15:2797.
    PubMed    
    Abstract available

  205. MABUCHI S, Sasano T, Komura N, Maeda M, et al
    Comparison of the Survival Outcomes of Minimally Invasive Surgery with Open Surgery in Patients with Uterine-Confined and Node-Negative Cervical Cancer: A Population-Based Study.
    Cancers (Basel). 2023;15:2756.
    PubMed    
    Abstract available

  206. FAN X, Wang Y, Yang N, Zhu P, et al
    Prognostic analysis of patients with stage IIIC1p cervical cancer treated by surgery.
    World J Surg Oncol. 2023;21:186.
    PubMed    
    Abstract available

  207. ZHU G, Xiong Z, Chen W, Zhu Z, et al
    Identification of key biomarkers and related immune cell infiltration in cervical cancer tissue based on bioinformatics analysis.
    Sci Rep. 2023;13:10121.
    PubMed    
    Abstract available

  208. ATADAG YB, Turkmen AT, Oksuz A, Keten HS, et al
    Changes in cancer screening process in primary care during the covid-19 pandemic. A record-based descriptive study.
    Saudi Med J. 2023;44:621-624.
    PubMed    
    Abstract available

  209. KUNDROD KA, Barra M, Wilkinson A, Smith CA, et al
    An integrated isothermal nucleic acid amplification test to detect HPV16 and HPV18 DNA in resource-limited settings.
    Sci Transl Med. 2023;15:eabn4768.
    PubMed    
    Abstract available

  210. NIU G, Wang H, Ren Y, Xing X, et al
    Penpulimab and anlotinib in an elderly patient with recurrent cervical cancer: a case report and literature review.
    Immunotherapy. 2023 Jun 21. doi: 10.2217/imt-2023-0020.
    PubMed    
    Abstract available

  211. LIU Y, Yang Z, Feng L, Xia Y, et al
    Advance in Nanomedicine for Improving Mucosal Penetration and Effective Therapy of Cervical Cancer.
    Small. 2023 Jun 20:e2303772. doi: 10.1002/smll.202303772.
    PubMed    
    Abstract available

  212. JITVAROPAS R, Thongpoom U, Sawaswong V, Khongnomnan K, et al
    Development of a simplified and cost-effective sample preparation method for genotyping of human papillomavirus by next-generation sequencing.
    Arch Virol. 2023;168:185.
    PubMed    
    Abstract available

  213. CINTRA GF, Derchain SFM, Bicalho DS, Filho ALDS, et al
    Cervical cancer in pregnancy.
    Rev Bras Ginecol Obstet. 2023;45:293-296.
    PubMed    


  214. LICHTENFELS M, Lorenzi NPC, Tacla M, Yokochi K, et al
    A New Brazilian Device for Cervical Cancer Screening: Acceptability and Accuracy of Self-sampling.
    Rev Bras Ginecol Obstet. 2023;45:235-241.
    PubMed    
    Abstract available

  215. WAN Z, Zhao J, Xu L, Sun P, et al
    Global and regional estimates of cervical cancer burden associated with human immunodeficiency virus infection from 1990 to 2019.
    J Med Virol. 2023;95:e28891.
    PubMed    
    Abstract available

  216. CARVALHO JP, Freitas D, Hanna S, Velho IA, et al
    Gemcitabine-Induced Radiation Recall Phenomenon in Cervical Cancer: A Case Report.
    Cureus. 2023;15:e39228.
    PubMed    
    Abstract available

  217. ALABDULKADER AM, AlAsfour A, Golembiewski M, Gullett H, et al
    Disparities in cervical cancer screening among Arabic-speaking women refugees.
    Ethn Health. 2023 Jun 19:1-13. doi: 10.1080/13557858.2023.2224953.
    PubMed    
    Abstract available

  218. BIZZARRI N, Querleu D, Dostalek L, van Lonkhuijzen LRCW, et al
    Survival associated with extent of radical hysterectomy in early-stage cervical cancer: a sub-analysis of the SCCAN collaborative study.
    Am J Obstet Gynecol. 2023 Jun 17:S0002-9378(23)00422.
    PubMed    
    Abstract available

  219. GHIMIRE R, Moore KL, Branco D, Rash DL, et al
    Forecasting patient-specific dosimetric benefit from daily online adaptive radiotherapy for cervical cancer.
    Biomed Phys Eng Express. 2023 Jun 19. doi: 10.1088/2057-1976.
    PubMed    
    Abstract available

  220. ZHAO K, Hu M, Yang R, Liu J, et al
    Decreasing expression of HIF-1alpha, VEGF-A, and Ki67 with efficacy of neoadjuvant therapy in locally advanced cervical cancer.
    Medicine (Baltimore). 2023;102:e33820.
    PubMed    
    Abstract available

  221. SONG Y, Wu Q
    RBM15 m(6) A modification-mediated OTUB2 upregulation promotes cervical cancer progression via the AKT/mTOR signaling.
    Environ Toxicol. 2023 Jun 19. doi: 10.1002/tox.23852.
    PubMed    
    Abstract available

  222. JI L, Chen M, Yao L
    Strategies to eliminate cervical cancer in China.
    Front Oncol. 2023;13:1105468.
    PubMed    
    Abstract available

  223. NZERIBE EA, Ododo NA, Eteike PO
    Profile of gynecological cancers in a tertiary hospital, Eastern Nigeria.
    Pan Afr Med J. 2023;44:139.
    PubMed    
    Abstract available

  224. PENG R, Cheng X, Zhang Y, Lu X, et al
    Corrigendum to "miR-214 down-regulates MKK3 and suppresses malignant phenotypes of cervical cancer cells" [Gene 724 (2020) 144146].
    Gene. 2023;877:147538.
    PubMed    


  225. GAO Q, Fan T, Luo S, Zheng J, et al
    Lactobacillus gasseri LGV03 isolated from the cervico-vagina of HPV-cleared women modulates epithelial innate immune responses and suppresses the growth of HPV-positive human cervical cancer cells.
    Transl Oncol. 2023;35:101714.
    PubMed    
    Abstract available

  226. GONZALEZ-RAMIREZ MI, Cardona YT, Agudelo MC, Lopez C, et al
    miRNAs signature as potential biomarkers for cervical precancerous lesions in human papillomavirus positive women.
    Sci Rep. 2023;13:9822.
    PubMed    
    Abstract available

  227. RIANO I, Contreras-Chavez P, Pabon CM, Meza K, et al
    An Overview of Cervical Cancer Prevention and Control in Latin America and the Caribbean Countries.
    Hematol Oncol Clin North Am. 2023 Jun 15:S0889-8588(23)00067.
    PubMed    
    Abstract available

  228. ZHENG P, Wu Y, Wang Y, Hu F, et al
    Disulfiram suppresses epithelial-mesenchymal transition (EMT), migration and invasion in cervical cancer through the HSP90A/NDRG1 pathway.
    Cell Signal. 2023;109:110771.
    PubMed    
    Abstract available

  229. AMPOFO AG, Boyes AW, Mackenzie LJ
    Preference For Cervical Cancer Education: A Multisite Cross-Sectional Survey of Female Senior High School Students in Ghana.
    J Cancer Educ. 2023 Jun 16. doi: 10.1007/s13187-023-02325.
    PubMed    
    Abstract available

  230. BUKOWSKI A, Smith JS, Wheeler SB, Sanusi B, et al
    Cervical Cancer Screening Knowledge, Perceptions, and Behaviors in a Multiracial Cohort of Low-Income, Underscreened Women in North Carolina.
    J Womens Health (Larchmt). 2023 Jun 16. doi: 10.1089/jwh.2022.0412.
    PubMed    
    Abstract available

  231. FREGA A, Gentili C, Proietti S, Lepore E, et al
    Epigallocatechin gallate, folic acid, vitamin B12, and hyaluronic acid significantly increase apoptosis and p53 expression in HeLa cells.
    Eur Rev Med Pharmacol Sci. 2023;27:5240-5245.
    PubMed    
    Abstract available

  232. MWENDA V, Jalang'o R, Miano C, Bor JP, et al
    Impact, cost-effectiveness, and budget implications of HPV vaccination in Kenya: A modelling study.
    Vaccine. 2023 Jun 7:S0264-410X(23)00546-7. doi: 10.1016/j.vaccine.2023.
    PubMed    
    Abstract available

  233. HUANG J, Song S, Wang M, Wang H, et al
    Transforming a highly toxic agent DM1 into injectable safe nanomedicines via prodrug self-assembly for the treatment of taxane-resistant cancer.
    Nanoscale. 2023;15:10110-10124.
    PubMed    
    Abstract available

  234. POOREBRAHIM M, Quiros-Fernandez I, Marme F, Burdach SE, et al
    A costimulatory chimeric antigen receptor targeting TROP2 enhances the cytotoxicity of NK cells expressing a T cell receptor reactive to human papillomavirus type 16 E7.
    Cancer Lett. 2023;566:216242.
    PubMed    
    Abstract available

  235. YANG Z, Zhang C, Luo P, Sun F, et al
    Genetic diversity and functional implication of the long control region in human papillomavirus types 52, 58, and 16 from Central China.
    Infect Genet Evol. 2023;112:105447.
    PubMed    
    Abstract available

  236. JONES TE, Matsko J, Elishaev E, Clark BZ, et al
    Changes over time in papanicolaou cytology test and HPV test in a large women's academic center laboratory.
    J Am Soc Cytopathol. 2023;12:307-313.
    PubMed    
    Abstract available

  237. SARR A, Ze Ondo C, Thiam A, Badji CA, et al
    [Epidemiological, etiological and evolutionary profile of vesico-vaginal fistulas in Senegal].
    Prog Urol. 2023;33:401-406.
    PubMed    
    Abstract available

  238. PARK S, Park D, Han S, Chung GE, et al
    LY6K depletion modulates TGF-beta and EGF signaling.
    Cancer Med. 2023;12:12593-12607.
    PubMed    
    Abstract available

  239. FENG Y, Zhu Z, Xu J, Sun L, et al
    Molecular Evolution of Human Parainfluenza Virus Type 2 Based on Hemagglutinin-Neuraminidase Gene.
    Microbiol Spectr. 2023;11:e0453722.
    PubMed    
    Abstract available

  240. CARROLL R, Tan KKH, Ker A, Byrne JL, et al
    Uptake, experiences and barriers to cervical screening for trans and non-binary people in Aotearoa New Zealand.
    Aust N Z J Obstet Gynaecol. 2023;63:448-453.
    PubMed    
    Abstract available

  241. KOMESAROFF PA
    Changing times in public health: The new wave of self-collection of invasive samples.
    Aust N Z J Obstet Gynaecol. 2023;63:473-475.
    PubMed    
    Abstract available

  242. STOLNICU S, Bartalis RJ, Mihut E, Szabo B, et al
    Cervical Pleuropulmonary Blastoma-like Tumor Associated With DICER1 and TP53 Mutations.
    Int J Gynecol Pathol. 2023;42:347-352.
    PubMed    
    Abstract available

  243. BAGUL C, Rao GK, Veena I, Kulkarni R, et al
    Benzimidazole-linked pyrazolo[1,5-a]pyrimidine conjugates: synthesis and detail evaluation as potential anticancer agents.
    Mol Divers. 2023;27:1185-1202.
    PubMed    
    Abstract available

  244. OKUNADE KS, Badmos KB, Soibi-Harry AP, Garba SR, et al
    Cervical Epithelial Abnormalities and Associated Factors among HIV-Infected Women in Lagos, Nigeria: A Cytology-Based Study.
    Acta Cytol. 2023;67:248-256.
    PubMed    
    Abstract available

  245. DUAN H, Li H, Kang S, Zhao H, et al
    Rationality of FIGO 2018 IIIC restaging of cervical cancer according to local tumor size: A cohort study.
    Acta Obstet Gynecol Scand. 2023 Jun 20. doi: 10.1111/aogs.14612.
    PubMed    
    Abstract available

  246. FRANCO EL
    The time has come to implement primary human papillomavirus screening for cervical cancer in the United States.
    Cancer. 2023 Jun 22. doi: 10.1002/cncr.34899.
    PubMed    


  247. ROSSI NM, Dai J, Xie Y, Wangsa D, et al
    Extrachromosomal Amplification of Human Papillomavirus Episomes Is a Mechanism of Cervical Carcinogenesis.
    Cancer Res. 2023;83:1768-1781.
    PubMed    
    Abstract available

  248. LI QS, Zheng PS
    ESRRB inhibits the TGF-beta signaling pathway to drive cell proliferation in cervical cancer.
    Cancer Res. 2023 Jun 23:CAN-23-0067. doi: 10.1158/0008-5472.CAN-23-0067.
    PubMed    
    Abstract available

  249. CHEN M, Li C, Cui Q, Zhou C, et al
    The efficacy of human papillomavirus prophylactic vaccination after conization in preventing cervical intraepithelial neoplasia recurrence: A prospective observational study in China.
    Eur J Obstet Gynecol Reprod Biol. 2023;286:10-15.
    PubMed    
    Abstract available

  250. LEVINE MD, Barrington DA, Meade CE, Lammers SM, et al
    Glassy cell carcinoma of the cervix: Findings from a combined National Cancer Database analysis and single institution review of treatment patterns and outcomes.
    Gynecol Oncol. 2023;173:15-21.
    PubMed    
    Abstract available

  251. KULKARNI A, Chen L, Gockley A, Khoury-Collado F, et al
    Patterns of cervical cancer screening follow-up in the era of prolonged screening intervals.
    Gynecol Oncol. 2023;175:53-59.
    PubMed    
    Abstract available

  252. QI L, Wang M, Jia Y, Wang Y, et al
    Impact of the COVID-19 pandemic on the hospital attendance of patients with primary cervical cancer in Heilongjiang, China.
    Int J Cancer. 2023 Jun 1. doi: 10.1002/ijc.34617.
    PubMed    
    Abstract available

  253. BONI SP, Horo A, Didi-Kouko-Coulibaly J, Tanon A, et al
    Impact of HIV infection on access to cancer care and survival among women with invasive cervical cancer in Cote d'Ivoire: A prospective cohort study.
    Int J Gynaecol Obstet. 2023 Jun 22. doi: 10.1002/ijgo.14925.
    PubMed    
    Abstract available

  254. KASUGA Y, Hasegawa K, Hamuro A, Fukuma Y, et al
    Pregnancy outcomes following radical trachelectomy for early-stage cervical cancer: A retrospective observational study in the Kanto area, Japan.
    Int J Gynaecol Obstet. 2023 Jun 21. doi: 10.1002/ijgo.14935.
    PubMed    
    Abstract available

  255. TOGAMI S, Tokudome A, Fukuda M, Mizuno M, et al
    Validation of single-photon emission computed tomography with computed tomography and lymphoscintigraphy for sentinel lymph node identification in cervical cancer.
    Int J Gynaecol Obstet. 2023 Jun 18. doi: 10.1002/ijgo.14917.
    PubMed    
    Abstract available

  256. DE LA CRUZ-RAMIREZ YM, Olaza-Maguina AF
    Barriers to HPV vaccine uptake in adolescents of the indigenous Andean community of Peru.
    Int J Gynaecol Obstet. 2023 May 5. doi: 10.1002/ijgo.14844.
    PubMed    


  257. MCCLYMONT E, Money D
    The shift to one-dose HPV vaccination: Where does this leave women living with HIV?
    Int J Gynaecol Obstet. 2023 Feb 20. doi: 10.1002/ijgo.14713.
    PubMed    


  258. VORA KS, Saiyed S, Joshi R, Natesan S, et al
    Prevalence of High Risk HPV amongst marginalized urban women in India and its implications on vaccination: A cross sectional study.
    Int J Gynaecol Obstet. 2022 Sep 1. doi: 10.1002/ijgo.14428.
    PubMed    
    Abstract available

  259. CHARGARI C, Tanderup K, Planchamp F, Chiva L, et al
    ESGO/ESTRO quality indicators for radiation therapy of cervical cancer.
    Int J Gynecol Cancer. 2023 May 31:ijgc-2022-004180.
    PubMed    
    Abstract available

  260. NGUYEN CGT, Phillips S, Chen A, Harrison R, et al
    Isolated tumor cells in a patient with early-stage cervical cancer.
    Int J Gynecol Cancer. 2023 Jun 2:ijgc-2022-004115. doi: 10.1136/ijgc-2022-004115
    PubMed    


  261. KOBAYASHI E, Takekuma M, Enomoto T, Okamoto A, et al
    Response to: Commentary on "Surgical skill and oncological outcome of laparoscopic radical hysterectomy: JGOG1081S-A1, an ancillary analysis of the Japanese Gynecologic Oncology Group Study JGOG1081" by Ramirez et al.
    Int J Gynecol Cancer. 2023;33:1012.
    PubMed    


  262. CORDOBA A, El Hajj H, Martinez-Gomez C, Hudry D, et al
    Should the cut-off for concomitant radiochemotherapy and intracavitary 3D adaptive uterovaginal brachytherapy be 3 cm?
    Int J Gynecol Cancer. 2023;33:1010-1011.
    PubMed    


  263. CASTILLO MH, Rodriguez R, Chavez C, Baltazar D, et al
    Control and management of gynecological cancer in Peru.
    Int J Gynecol Cancer. 2023;33:995-996.
    PubMed    


  264. OBERMAIR A, Leitao M
    Correspondence on "ESGO/ESTRO/ESP guidelines fpr the management of patients with cervical cancer: update 2023" by Cibula et al.
    Int J Gynecol Cancer. 2023 Jun 15:ijgc-2023-004645.
    PubMed    


  265. PAREJA R, Heredia F, Leitao M
    Correspondence on 'ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer - Update 2023*'.
    Int J Gynecol Cancer. 2023 Jun 9:ijgc-2023-004656. doi: 10.1136/ijgc-2023-004656
    PubMed    


  266. ALCANIZ BOADA E, Cuschieri K, Graham C, Moncur S, et al
    Agreement between L1 and E6/E7-based assays for detection of high-risk HPV in cervical, oropharyngeal and penile cancers.
    J Clin Pathol. 2022 Feb 8. pii: jclinpath-2021-208054.
    PubMed    
    Abstract available

  267. ELASIFER H, Amukwaya MMN, Bhatia R, Cuschieri K, et al
    The role of circulating viral and tumour DNA in the diagnosis and management of HPV associated anogenital cancers, a systematic review and meta-analysis.
    J Clin Virol. 2023;164:105469.
    PubMed    
    Abstract available

  268. CHARGARI C, Tanderup K, Planchamp F, Chiva L, et al
    ESGO/ESTRO quality indicators for radiation therapy of cervical cancer.
    Radiother Oncol. 2023;183:109589.
    PubMed    
    Abstract available

  269. CIBULA D, Rosaria Raspollini M, Planchamp F, Centeno C, et al
    ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer - Update 2023.
    Radiother Oncol. 2023;184:109682.
    PubMed    
    Abstract available

  270. ECKER S, Kirisits C, Schmid M, Knoth J, et al
    EviGUIDE - A tool for evidence-based decision making in image-guided adaptive brachytherapy for cervical cancer.
    Radiother Oncol. 2023 Jun 15:109748. doi: 10.1016/j.radonc.2023.109748.
    PubMed    
    Abstract available

  271. WU J, Guo Q, Zhu J, Wu Y, et al
    Developing a nomogram for preoperative prediction of cervical cancer lymph node metastasis by multiplex immunofluorescence.
    BMC Cancer. 2023;23:485.
    PubMed    
    Abstract available

  272. JIANG Y, Wang J, Jiang P, Wang X, et al
    Clinical research of the value of high-risk CTV setting on intensity-modulated radiotherapy for stage IIB-IVA cervical cancer.
    BMC Cancer. 2023;23:481.
    PubMed    
    Abstract available

  273. JEMAL Z, Chea N, Hasen H, Tesfaye T, et al
    Cervical cancer screening utilization and associated factors among female health workers in public health facilities of Hossana town, southern Ethiopia: A mixed method approach.
    PLoS One. 2023;18:e0286262.
    PubMed    
    Abstract available

  274. MWENDA V, Bor JP, Nyangasi M, Njeru J, et al
    Integrating human papillomavirus testing as a point-of care service using GeneXpert platforms: Findings and lessons from a Kenyan pilot study (2019-2020).
    PLoS One. 2023;18:e0286202.
    PubMed    
    Abstract available

  275. FUJITA M, Nagashima K, Shimazu M, Suzuki M, et al
    Acceptability of self-sampling human papillomavirus test for cervical cancer screening in Japan: A questionnaire survey in the ACCESS trial.
    PLoS One. 2023;18:e0286909.
    PubMed    
    Abstract available

  276. ALAM Z, Cairns JM, Scott M, Dean JA, et al
    Interventions to increase cervical screening uptake among immigrant women: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0281976.
    PubMed    
    Abstract available

  277. VAINER G, Huang L, Emancipator K, Nuti S, et al
    Equivalence of laboratory-developed test and PD-L1 IHC 22C3 pharmDx across all combined positive score indications.
    PLoS One. 2023;18:e0285764.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.


;